Home › Drug Codes › J Codes › J2919 · METHYLPREDNISOLONE SODIUM SUCCINATE
Updated July 1st, 2026

METHYLPREDNISOLONE SODIUM SUCCINATE J Code: J2919

Injection, methylprednisolone sodium succinate, 5 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J2919, effective October 1, 2026: $0.255 per HCPCS billing unit, up 13.8% from $0.224. From CMS's final file.

?
Medicare Payment Limit ?
$0.224
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
Not published
CMS publishes none for Q3 2026
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
32
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, methylprednisolone sodium succinate, 5 mg
HCPCS Added Date April 1, 2024
Manufacturer Multiple Manufacturers
Route of Administration Intramuscular, Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose, Multi-Dose
Dosage Form Injection | Injection, Powder, For Solution | Injection, Powder, Lyophilized, For Solution

About METHYLPREDNISOLONE SODIUM SUCCINATE

Methylprednisolone Sodium Succinate is a medication aligned to the HCPCS J Code: J2919 for billing, pricing, and reimbursement purposes in the United States. This Misc. medication is administered via the intramuscular or intravenous routes and manufactured by multiple companies.

According to CMS Drug Use Information: This medication is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. Methylprednisolone is a corticosteroid hormone. This injectable form of methylprednisolone is used when a similar drug cannot be taken by mouth or when a very fast response is needed, especially in patients with severe medical conditions. Talk to your doctor about the risks and benefits of methylprednisolone, especially if it is to be injected near your spine (epidural). Rare but serious side effects may occur with epidural use. Methylprednisolone may also be used with other medications in hormone disorders.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 32 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00009-0003-02 Solu-Medrol Pharmacia & Upjohn Company LLC 100 500 MG / 4 ML
00143-9753-25 Methylprednisolone Sodium Succinate Hikma Pharmaceuticals USA Inc. 200 40 MG
43598-0127-25 Methylprednisolone sodium succinate Dr. Reddy's Laboratories Inc 200 40 MG / 1 ML
50090-0271-00 Solu-Medrol A-S Medication Solutions 25 125 MG / 2 ML
63323-0255-03 Methylprednisolone Sodium Succinate Fresenius Kabi USA, LLC 200 40 MG / 1 ML
•••••-••••-•• Log in to view METHYLPREDNISOLONE SODIUM SUCCINATE
METHYLPREDNISOLONE SODIUM SUCCINATE
METHYLPREDNISOLONE SODIUM SUCCINATE
Login to view 27 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

METHYLPREDNISOLONE SODIUM SUCCINATE Pricing & Reimbursement

J2919 Private Payer Reimbursement
$0.62 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

Methylprednisolone Sodium Succinate 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J2919 Generic Code (Multiple Manufacturers) Methylprednisolone Sodium Succinate Injection, methylprednisolone sodium succinate, 5 mg

METHYLPREDNISOLONE SODIUM SUCCINATE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
96374 Login for More Therapeutic, prophylactic, or diagnostic injection (specify substance or drug), IV push, single, or initial substance/drug Login for More
Not on the CMS JW / JZ list

This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →

METHYLPREDNISOLONE SODIUM SUCCINATE Medically Unlikely Edits (MUE)

The most billing units of J2919 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 5 mg.

Practitioner Office & Hospital Outpatient
5,400 units / day
= 27,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

METHYLPREDNISOLONE SODIUM SUCCINATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Acute exacerbations of multiple sclerosis All indications — pediatric (general) All labeled indications Allergic states Allergic states (asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, serum sickness, transfusion reactions) Allergic states — asthma uncontrolled by inhaled corticosteroids and long-acting bronchodilators Allergic states — pediatric asthma Asthma Asthma (pediatric, uncontrolled by inhaled corticosteroids and long-acting bronchodilators) Cerebral edema associated with primary or metastatic brain tumor, or craniotomy Corticosteroid-responsive conditions (all labeled indications) Dermatologic diseases Dermatologic diseases (bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme) Endocrine disorders Endocrine disorders (adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Endocrine disorders (primary or secondary adrenocortical insufficiency, congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis) Gastrointestinal diseases Gastrointestinal diseases (regional enteritis, ulcerative colitis) Hematologic disorders Hematologic disorders (acquired hemolytic anemia, Diamond-Blackfan anemia, idiopathic thrombocytopenic purpura, pure red cell aplasia, secondary thrombocytopenia) Hematologic disorders (autoimmune hemolytic anemia, Diamond-Blackfan anemia, idiopathic thrombocytopenic purpura, pure red cell aplasia, secondary thrombocytopenia) Leukemias and lymphomas Miscellaneous (trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block) Miscellaneous (trichinosis with neurologic/myocardial involvement, tuberculous meningitis with subarachnoid block) Miscellaneous (trichinosis, tuberculous meningitis) Multiple indications — pediatric patients (general) Multiple sclerosis Multiple sclerosis, acute exacerbations Neoplastic diseases (leukemias and lymphomas) Neoplastic diseases (leukemias, lymphomas) Nervous system disorders (cerebral edema, brain tumor/craniotomy) Ophthalmic diseases Ophthalmic diseases (sympathetic ophthalmia, uveitis, ocular inflammatory conditions) Renal diseases Renal diseases (idiopathic nephrotic syndrome or nephrotic syndrome due to lupus erythematosus) Renal diseases (idiopathic nephrotic syndrome, nephrotic syndrome due to lupus erythematosus) Renal diseases (nephrotic syndrome) Respiratory diseases Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, sarcoidosis) Respiratory diseases (berylliosis, pulmonary tuberculosis, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis) Rheumatic disorders Rheumatic disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, dermatomyositis, temporal arteritis, polymyositis, systemic lupus erythematosus) Rheumatic disorders (acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, dermatomyositis, temporal arteritis, polymyositis, systemic lupus erythematosus) Trichinosis with neurologic or myocardial involvement Trichinosis with neurologic or myocardial involvement and tuberculous meningitis Trichinosis with neurologic or myocardial involvement; tuberculous meningitis with subarachnoid block or impending block Tuberculous meningitis with subarachnoid block or impending block
Drug Class
Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.
Access Full Report →

Frequently Asked Questions

Is a Methylprednisolone Sodium Succinate billing and coding guide available?
We have not yet identified a manufacturer source of billing and coding information for Methylprednisolone Sodium Succinate
Is Methylprednisolone Sodium Succinate patient assistance information available?
Our team did not identify a source for Methylprednisolone Sodium Succinate patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Methylprednisolone Sodium Succinate prescribing information?
Our team is still working to identify a source of prescribing information for METHYLPREDNISOLONE SODIUM SUCCINATE
Where can I find Methylprednisolone Sodium Succinate side effect information?
Our team has not yet identified a source of side effect information for METHYLPREDNISOLONE SODIUM SUCCINATE
Does billing METHYLPREDNISOLONE SODIUM SUCCINATE require JZ/JW wastage modifiers?
CMS does not include METHYLPREDNISOLONE SODIUM SUCCINATE (J2919) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing J2919. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.

Related Drug Codes

Explore billing, coding, and pricing for drugs related to METHYLPREDNISOLONE SODIUM SUCCINATE.

J2920METHYLPREDNISOLONE SODIUM SUCCInjection, methylprednisolone sodium succinate, up to 40 mgMultiple ManufacturersAdded January 1, 1982J2930METHYLPREDNISOLONE SODIUM SUCCInjection, methylprednisolone sodium succinate, up to 125 mgMultiple ManufacturersAdded January 1, 1984J1010METHYLPREDNISOLONE ACETATEInjection, methylprednisolone acetate, 1 mgMultiple ManufacturersAdded April 1, 2024J1100Dexamethasone Sodium PhosphateInjection, dexamethasone sodium phosphate, 1 mgMultiple ManufacturersAdded January 1, 1982J3301KENALOG-10Injection, triamcinolone acetonide, not otherwise specified, 10 mgMultiple ManufacturersAdded January 1, 1991J7509MEDROLMethylprednisolone oral, per 4 mgMultiple ManufacturersAdded January 1, 1996J7510PREDNISOLONEPrednisolone oral, per 5 mgMultiple ManufacturersAdded January 1, 1996J7512PrednisonePrednisone, immediate release or delayed release, oral, 1 mgMultiple ManufacturersAdded January 1, 2016J8540DEXAMETHASONEDexamethasone, oral, 0.25 mgMultiple ManufacturersAdded January 1, 2006J0517FASENRAInjection, benralizumab, 1 mgAstrazenecaAdded January 1, 2019